女性糖尿病和类风湿关节炎患者药物协同作用引起的低血糖发作

Interventions in Obesity & Diabetes Pub Date : 2020-05-15 DOI:10.31031/IOD.2020.04.000580

Argyrios V Tsakalis

{"title":"女性糖尿病和类风湿关节炎患者药物协同作用引起的低血糖发作","authors":"Argyrios V Tsakalis","doi":"10.31031/IOD.2020.04.000580","DOIUrl":null,"url":null,"abstract":"Hydroxychloroquine (HCQ) and Leflunomide (LE) are agents that are commonly used to treat rheumatoid arthritis. Type 2 Diabetes (DM2) patients are in increased risk of hypoglycemia. The present report documents a case of repeated dawn hypoglycemic episodes due to concomitant use of HCQ, LE and Repaglinide in a patient with Rheumatoid arthritis and DM2.","PeriodicalId":170669,"journal":{"name":"Interventions in Obesity & Diabetes","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hypoglycemic Episodes Due to Synergistic Effect of Drugs in a Woman with Diabetes and Rheumatoid Arthritis\",\"authors\":\"Argyrios V Tsakalis\",\"doi\":\"10.31031/IOD.2020.04.000580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hydroxychloroquine (HCQ) and Leflunomide (LE) are agents that are commonly used to treat rheumatoid arthritis. Type 2 Diabetes (DM2) patients are in increased risk of hypoglycemia. The present report documents a case of repeated dawn hypoglycemic episodes due to concomitant use of HCQ, LE and Repaglinide in a patient with Rheumatoid arthritis and DM2.\",\"PeriodicalId\":170669,\"journal\":{\"name\":\"Interventions in Obesity & Diabetes\",\"volume\":\"36 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interventions in Obesity & Diabetes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31031/IOD.2020.04.000580\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventions in Obesity & Diabetes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31031/IOD.2020.04.000580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

羟氯喹(HCQ)和来氟米特(LE)是通常用于治疗类风湿性关节炎的药物。2型糖尿病(DM2)患者低血糖的风险增加。本报告记录了一例类风湿关节炎和DM2患者因同时使用HCQ、LE和瑞格列奈而反复出现黎明低血糖发作的病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Hypoglycemic Episodes Due to Synergistic Effect of Drugs in a Woman with Diabetes and Rheumatoid Arthritis

Hydroxychloroquine (HCQ) and Leflunomide (LE) are agents that are commonly used to treat rheumatoid arthritis. Type 2 Diabetes (DM2) patients are in increased risk of hypoglycemia. The present report documents a case of repeated dawn hypoglycemic episodes due to concomitant use of HCQ, LE and Repaglinide in a patient with Rheumatoid arthritis and DM2.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Interventions in Obesity & Diabetes

自引率

0.00%

发文量